IRIS
MANCINI, NICASIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 5.429
AS - Asia 4.259
NA - Nord America 4.046
SA - Sud America 1.103
Continente sconosciuto - Info sul continente non disponibili 340
AF - Africa 105
OC - Oceania 9
Totale 15.291
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.788
RU - Federazione Russa 2.792
SG - Singapore 1.422
CN - Cina 1.358
IT - Italia 1.062
BR - Brasile 894
SE - Svezia 613
HK - Hong Kong 545
VN - Vietnam 419
FR - Francia 224
DE - Germania 202
CA - Canada 129
GB - Regno Unito 118
IN - India 109
BD - Bangladesh 96
FI - Finlandia 92
NL - Olanda 78
AR - Argentina 77
MX - Messico 62
PL - Polonia 51
AT - Austria 47
EC - Ecuador 43
JP - Giappone 43
IE - Irlanda 42
ZA - Sudafrica 42
TR - Turchia 36
ES - Italia 34
IQ - Iraq 34
ID - Indonesia 32
CO - Colombia 27
SA - Arabia Saudita 21
UZ - Uzbekistan 20
PH - Filippine 15
PK - Pakistan 15
PY - Paraguay 14
CL - Cile 13
CR - Costa Rica 13
JM - Giamaica 13
LT - Lituania 13
MA - Marocco 12
MY - Malesia 12
PE - Perù 12
VE - Venezuela 12
AE - Emirati Arabi Uniti 10
TN - Tunisia 10
IR - Iran 9
JO - Giordania 9
TT - Trinidad e Tobago 9
UA - Ucraina 9
EG - Egitto 8
RO - Romania 8
AU - Australia 7
BE - Belgio 7
DZ - Algeria 7
HN - Honduras 7
NI - Nicaragua 7
NP - Nepal 7
AZ - Azerbaigian 6
KE - Kenya 6
UY - Uruguay 6
DK - Danimarca 5
HU - Ungheria 5
KZ - Kazakistan 5
RS - Serbia 5
DO - Repubblica Dominicana 4
GA - Gabon 4
GD - Grenada 4
IL - Israele 4
TH - Thailandia 4
AL - Albania 3
BH - Bahrain 3
CH - Svizzera 3
CM - Camerun 3
GT - Guatemala 3
GY - Guiana 3
HR - Croazia 3
KH - Cambogia 3
KR - Corea 3
MU - Mauritius 3
PA - Panama 3
PS - Palestinian Territory 3
TW - Taiwan 3
A1 - Anonimo 2
AM - Armenia 2
BO - Bolivia 2
BS - Bahamas 2
BY - Bielorussia 2
CI - Costa d'Avorio 2
CZ - Repubblica Ceca 2
EU - Europa 2
KG - Kirghizistan 2
KW - Kuwait 2
LB - Libano 2
MD - Moldavia 2
NZ - Nuova Zelanda 2
PT - Portogallo 2
SN - Senegal 2
AF - Afghanistan, Repubblica islamica di 1
AO - Angola 1
BG - Bulgaria 1
Totale 14.940
Salva come PNG Salva come JPEG
Città #
Singapore 630
Moscow 606
Dallas 557
Ashburn 545
Hong Kong 541
San Jose 370
Milan 296
Shanghai 291
Beijing 198
Council Bluffs 198
Hefei 187
New York 167
Ho Chi Minh City 165
Lauterbourg 162
Princeton 153
Lawrence 150
Los Angeles 106
São Paulo 91
Hanoi 85
Rome 74
Santa Clara 70
Munich 59
Helsinki 58
Warsaw 46
Chennai 43
Orem 43
Nuremberg 42
Turin 39
Montreal 37
Stockholm 37
Florence 36
Dublin 34
Tokyo 34
Atlanta 32
Johannesburg 32
Boardman 31
Brescia 31
London 31
Denver 30
Toronto 30
Bologna 28
Brooklyn 28
Poplar 27
Houston 26
Mexico City 26
Chicago 25
Belo Horizonte 24
Seattle 24
Turku 24
Boston 22
Cesano Boscone 22
Phoenix 22
Guangzhou 21
Frankfurt am Main 20
Rio de Janeiro 20
Vienna 20
Haiphong 19
Amsterdam 18
Falkenstein 18
Shenzhen 18
The Dalles 18
Tashkent 17
Campinas 15
Catania 14
Da Nang 14
Porto Alegre 14
San Francisco 14
Brasília 13
Columbus 13
Curitiba 13
Hangzhou 13
Manchester 13
Omaha 13
Pune 13
Washington 13
Ankara 12
Guayaquil 12
Mumbai 12
Naples 12
Salvador 12
Tianjin 12
Baghdad 11
Biên Hòa 11
Quito 11
Sorocaba 11
Genoa 10
Guarulhos 10
San José 10
Bogotá 9
Dhaka 9
Lappeenranta 9
Miami 9
Paris 9
Verona 9
Amman 8
Barnet 8
Calgary 8
Changsha 8
Jakarta 8
Jeddah 8
Totale 7.277
Salva come PNG Salva come JPEG
Nome #
A modified Frosch approach for posterior tibial plateau fractures: Technical note and case series 708
A Human Stem Cell-Derived Neurosensory–Epithelial Circuitry on a Chip to Model Herpes Simplex Virus Reactivation 230
Beauveria bassiana Keratitis: A Case Series and Review of Literature 181
High Risk of Secondary Infections Following Thrombotic Complications in Patients With COVID-19 180
COVID-eVax, an electroporated DNA vaccine candidate encoding the SARS-CoV-2 RBD, elicits protective responses in animal models 174
Biobanking for COVID-19 research 149
Levofloxacin prophylaxis vs no prophylaxis in neutropenic patients within an endemic country for carbapenem-resistant GNB 147
Nanopore ReCappable sequencing maps SARS-CoV-2 5' capping sites and provides new insights into the structure of sgRNAs 147
The interferon landscape along the respiratory tract impacts the severity of COVID-19 142
Answer to Photo Quiz: Scolecobasidium sp 137
A Biologically-validated HCV E1E2 Heterodimer Structural Model 134
Antibody Titer Kinetics and SARS-CoV-2 Infections Six Months after Administration with the BNT162b2 Vaccine 134
Interferon-β 1a inhibits SARS-CoV-2 in vitro when administered after virus infection 132
Cloning of the first human anti-JCPyV/VP1 neutralizing monoclonal antibody: Epitope definition and implications in risk stratification of patients under natalizumab therapy 130
A phage display vector optimized for the generation of human antibody combinatorial libraries and the molecular cloning of monoclonal antibody fragments 130
A Human Monoclonal Antibody with Neutralizing Activity against Highly Divergent Influenza Subtypes 129
Combined Prophylactic and Therapeutic Use Maximizes Hydroxychloroquine Anti-SARS-CoV-2 Effects in vitro 129
A spatial multi-scale fluorescence microscopy toolbox discloses entry checkpoints of SARS-CoV-2 variants in Vero E6 cells 128
Cell-to-cell spread-blocking activity is extremely limited in the sera of HSV-1 and HSV-2 infected subjects 127
Unconventional CD147-dependent platelet activation elicited by SARS-CoV-2 in COVID-19 126
ACOD1 deficiency offers protection in a mouse model of diet-induced obesity by maintaining a healthy gut microbiota 125
Antibiotic appropriateness for Gram-negative bloodstream infections: impact of infectious disease consultation 123
Heparin Inhibits Cellular Invasion by SARS-CoV-2: Structural Dependence of the Interaction of the Spike S1 Receptor-Binding Domain with Heparin 121
A non-VH1-69 heterosubtypic neutralizing human monoclonal antibody protects mice against H1N1 and H5N1 viruses 120
Cardiac implantable electronic device infections: impact of initiation of antimicrobial treatment before or after device removal on microbiological yield 119
Mechanisms of Hepatitis C Virus Escape from Vaccine-Relevant Neutralizing Antibodies 118
Analysis of the faecal microbiome during analytical treatment interruption in people with chronic HIV infection and long-lasting virological suppression (APACHE study) 115
A potential role for monoclonal antibodies in prophylactic and therapeutic treatment of influenza 114
Recognition and inhibition of SARS-CoV-2 by humoral innate immunity pattern recognition molecules 112
ANTI-HIV-1 RESPONSE ELICITED IN RABBITS BY ANTI-IDIOTYPE MONOCLONAL ANTIBODIES MIMICKING THE CD4-BINDING SITE ON GP120 111
Lower nasopharyngeal viral load during the latest phase of COVID-19 pandemic in a Northern Italy University Hospital 110
A new case of Echovirus 11 neonatal fulminant hepatitis involving male twins in a Northern Italy Tertiary University Hospital: Insight on a possible immunological clue 108
Single spike mutation differentiating XBB.1 and XBB.1.5 enhances SARS-CoV-2 cell-to-cell transmission and facilitates serum-mediated enhancement 107
Differential plasmacytoid dendritic cell phenotype and type I Interferon response in asymptomatic and severe COVID-19 infection 107
The efficacy of ultraviolet light-emitting technology against coronaviruses: a systematic review 106
Dose-Dependent Impairment of the Immune Response to the Moderna-1273 mRNA Vaccine by Mycophenolate Mofetil in Patients with Rheumatic and Autoimmune Liver Diseases 105
Adoptive T-cell therapy in the treatment of viral and opportunistic fungal infections 105
Differential composition of vaginal microbiome, but not of seminal microbiome, is associated with successful intrauterine insemination in couples with idiopathic infertility: A prospective observational study 105
Novel therapeutic investigational strategies to treat severe and disseminated HSV infections suggested by a deeper understanding of in vitro virus entry processes 105
Smallpox vaccination-elicited antibodies cross-neutralize 2022-Monkeypox virus Clade II 104
JC polyomavirus (JCV) and monoclonal antibodies: friends or potential foes? 104
A case of psoriatic arthritis triggered by SARS-CoV-2 infection 104
Acute respiratory distress in a neutropenic febrile patient after hematopoietic cell transplantation 101
A closer look at prion strains: Characterization and important implications 101
Broadly neutralizing anti-influenza human monoclonal antibodies and their possible role in predictive medicine 101
IN VIVO PROTECTION CONFERRED BY HUMAN MONOCLONAL ANTIBODY DIRECTED AGAINST HSV-1 AND 2 101
Neutralization Interfering Antibodies: a "Novel" Mechanism of Humoral Immune Mutiny and Viral Evasion? 99
Detection of low-level HCV variants in DAA treated patients: comparison amongst three different NGS data analysis protocols 99
Heterosubtypic protection conferred by the human monoclonal antibody PN-SIA28 against influenza A virus lethal infections in mice 96
A novel expression vector for production of epitope-tagged recombinant Fab-fragment in bacteria 96
Anti-HIV-1 response elicited in rabbits by anti-idiotype monoclonal antibodies mimicking the CD4-binding site 95
IFCC interim guidelines on biochemical/hematological monitoring of COVID-19 patients 94
Fast inactivation of SARS-CoV-2 by UV-C and ozone exposure on different materials 94
Chimeric antigen receptor (CAR)-engineered T cells redirected against hepatitis C virus (HCV) E2 glycoprotein 94
An outbreak caused by multidrug-resistant OXA-58-positive Acinetobacter baumannii in an intensive care unit in Italy 93
Entry inhibition of HSV-1 and -2 protects mice from viral lethal challenge 93
Proper Selection of In Vitro Cell Model Affects the Characterization of the Neutralizing Antibody Response against SARS-CoV-2 91
JN.1 variants circulating in Italy from October 2023 to April 2024: genetic diversity and immune recognition 90
Antibiotic resistance among sexually transmitted infections: perspectives from clinical practice 89
Weak correlation between antibody titers and neutralizing activity in sera from SARS-CoV-2 infected subjects 87
Characterization of two human monoclonal anti-E2/HCV antibodies for potential application in prevention and treatment of HCV infection 86
Antigen-driven evolution of B lymphocytes in coronary atherosclerotic plaques 86
Analysis of the Enteric Microbiome: First Tentative Steps Towards a Comprehensive Work-up of Prostate Cancer? 86
Natural Flavonoid Derivatives Have Pan-Coronavirus Antiviral Activity 86
Answer to February 2019 Photo Quiz: Neurological Symptoms in a 74-Year-Old Diabetic Woman Admitted to the Emergency Room 85
Adjuvant role of SeptiFast to improve the diagnosis of sepsis in a large cohort of hematological patients 85
Global and local envelope protein dynamics of hepatitis C virus determine broad antibody sensitivity 85
Harmonization of six quantitative SARS-CoV-2 serological assays using sera of vaccinated subjects 85
Influenza B-cells protective epitope characterization: a passkey for the rational design of new broad-range anti-influenza vaccines 84
Identification of a novel mutation involved in colistin resistance in Klebsiella pneumoniae through Next-Generation Sequencing (NGS) based approaches 83
Genetic characterization of Klebsiella pneumoniae carbapenemase -producing Klebsiella pneumoniae isolates with different susceptibility to ceftazidime/avibactam in patients with blood-stream infections 83
Clinical characterization and whole genome sequence-based typing of two cases of endophthalmitis due to Listeria monocytogenes 83
Characterization of a lineage c.36 sars-cov-2 isolate with reduced susceptibility to neutralization circulating in lombardy, italy 83
Synergistic neutralization of HCV by two broadly neutralizing human monoclonal antibodies 82
Epitope mapping by epitope excision, hydrogen/deuterium exchange, and peptide-panning techniques combined with in silico analysis 81
Naringenin is a powerful inhibitor of SARS-CoV-2 infection in vitro 80
Sex-specific Alterations in the Urinary and Tissue Microbiome in Therapy-naïve Urothelial Bladder Cancer Patients 80
Circulating SARS-CoV-2 variants in Italy, October 2020–March 2021 80
Dual-Domain Reporter Approach for Multiplex Identification of Major SARS-CoV-2 Variants of Concern in a Microarray-Based Assay 80
Characterization of epitopes recognized by monoclonal antibodies: experimental approaches supported by freely accessible bioinformatic tools 79
Role and potential therapeutic use of antibodies against herpetic infections 79
IFCC interim guidelines on rapid point-of-care antigen testing for SARS-CoV-2 detection in asymptomatic and symptomatic individuals 79
Microbiome Markers are Early Predictors of Acute GvHD in Allogeneic Hematopoietic Stem Cell Transplant recipients 78
Broadly neutralizing human monoclonal antibodies: a novel resource against influenza viruses 78
Molecular characterization of the human neutralizing response against hepatitis C virus and its role in the prediction of the infection outcome 78
HCV E2 core structures and mAbs: something is still missing 77
Coronaviridae and SARS-associated coronavirus strain HSR1 76
Unveiling the role of PUS7-mediated pseudouridylation in host protein interactions specific for the SARS-CoV-2 RNA genome 72
Virus-induced preferential antibody gene-usage and its importance in humoral autoimmunity 72
Molecular diagnosis of sepsis in neutropenic patients with haematological malignancies 72
Geographical and temporal distribution of SARS-CoV-2 clades in the WHO European Region, January to June 2020 72
Reply to: Hultström et al., Genetic determinants of mannose-binding lectin activity predispose to thromboembolic complications in critical COVID-19. Mannose-binding lectin genetics in COVID-19 71
Microbiological Diagnosis of Sepsis: The Confounding Effects of a “Gold Standard” 71
Very high SARS-CoV-2 load at the emergency department presentation strongly predicts the risk of admission to the intensive care unit and death 71
Viral Respiratory Pathogens and Lung Injury 71
Interferon β-1a (IFNβ-1a) in COVID-19 patients (INTERCOP): study protocol for a randomized controlled trial 70
SARS-CoV-2 detection in primary thyroid sarcoma: coincidence or interaction? 69
HUMAN MONOCLONAL ANTIBODY ENDOWED WITH ANTI-HSV-1 AND -2 ACTIVITY STRONGLY INHIBITS VIRUS REPLICATION 69
Monoclonal antibodies isolated from human B cells neutralize a broad range of H1 subtype influenza A viruses including swine-origin Influenza virus (S-OIV) 68
Type III interferons disrupt the lung epithelial barrier upon viral recognition 66
Totale 10.777
Salva come PNG Salva come JPEG
Categoria #
all - tutte 88.272
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 88.272
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022139 0 7 20 29 13 7 13 9 4 10 6 21
2022/20231.082 350 259 98 15 22 127 62 65 49 7 14 14
2023/2024756 27 40 101 92 53 149 34 70 9 23 42 116
2024/20252.998 314 65 68 111 124 240 434 367 494 301 237 243
2025/20269.379 692 716 760 1.319 731 327 754 674 2.493 444 204 265
2026/2027739 367 372 0 0 0 0 0 0 0 0 0 0
Totale 15.291